Benzocaine Otic Solution — Competitive Intelligence Brief

Benzocaine Otic Solution (Benzocaine Otic Solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Otology / Pain Management.

phase 3 Local anesthetic Voltage-gated sodium channels Otology / Pain Management Small molecule

Target snapshot

Benzocaine Otic Solution (Benzocaine Otic Solution) — Lachlan Pharma Holdings. Benzocaine is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission in the ear.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Benzocaine Otic Solution TARGET	Benzocaine Otic Solution	Lachlan Pharma Holdings	phase 3	Local anesthetic	Voltage-gated sodium channels
Ropivacaine 0,75% in PENG block	Ropivacaine 0,75% in PENG block	University of Liege	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
liposomal bupivacaine local infiltration	liposomal bupivacaine local infiltration	Second Affiliated Hospital, School of Medicine, Zhejiang University	marketed	Local anesthetic	Voltage-gated sodium channels
intraarticular injection with ropivacaine	intraarticular injection with ropivacaine	Hvidovre University Hospital	marketed	Local anesthetic	Voltage-gated sodium channels
Remifentanil+Lidocaine	Remifentanil+Lidocaine	The First Affiliated Hospital of Zhengzhou University	marketed	Opioid analgesic + Local anesthetic combination	Mu-opioid receptor (remifentanil); Voltage-gated sodium channels (lidocaine)
Exparel/bupivacaine mixture	Exparel/bupivacaine mixture	Wake Forest University Health Sciences	marketed	Local anesthetic (liposomal formulation)	Voltage-gated sodium channels
Compound lidocaine	Compound lidocaine	Tianjin Medical University General Hospital	marketed	Local anesthetic	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

1. University of California, San Diego · 3 drugs in this class
2. Durect · 3 drugs in this class
3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
4. Wake Forest University Health Sciences · 3 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Imperial College London · 2 drugs in this class
7. Hvidovre University Hospital · 2 drugs in this class
8. Innocoll · 2 drugs in this class
9. George Washington University · 2 drugs in this class
10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class